QSAR, docking studies and pharmacophore identification of phenylmethyl phenoxy propyl amino propanoic acid derivatives as leukotriene A 4 hydrolase inhibitors

Yaoxue Xuebao

Volumn 45, Issue 5, 2010, Pages 615-623

  Sonawane, Lalit V ^a   Bari, Sanjaykumar B ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Docking; LTA 4 hydrolase; Molecular descriptor; Pharmacophore; QSAR

Indexed keywords

HYDROLASE INHIBITOR; LEUKOTRIENE A4 HYDROLASE; PHENYLMETHYL PHENOXY PROPYL AMINO PROPANOIC ACID; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; DRUG SYNTHESIS; ENZYME BINDING; HYPOTHESIS; IC 50; MOLECULAR DOCKING; MOLECULAR MODEL; PHARMACOPHORE; PROTEIN ANALYSIS; PROTEIN TARGETING; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

BETA-ALANINE; CATALYTIC DOMAIN; DATABASES, FACTUAL; ENZYME INHIBITORS; EPOXIDE HYDROLASES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOFTWARE;

EID: 77954596513     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bray MA. Leukotrienes in inflammation [J]. Inflamm Res, 1986, 19: 87-99.
2. Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease [J]. Gastroenterology, 1984, 86: 453-460. (Pubitemid 14154655)
3. Drazen JM, Dahlen SE, Lee TH. Five-Lipoxygenase Products in Asthma [M]. New York: Marcell Dekker Inc., 1998.
4. O'Driscoll BRC, Cromwell O, Kay AB. Sputum leukotrienes in obstructive airways disease [J]. Clin Exp Immunol, 1984, 55: 397-404. (Pubitemid 14223478)
5. Bigby TD, Lee DM, Meslier N, et al. Leukotriene A4 hydrolase activity of human airway epithelial cells [J]. Biochem Biophys Res Commun, 1989, 164: 1-7. (Pubitemid 19269687)
6. Munafo DA, Shindo K, Baker JR, et al. Leukotriene A(4) hydrolase in human bronchoalveolar lavage fluid [J]. J Clin Invest, 1994, 93: 1042-1050.
7. Goodarzi K, Goodarzi M, Tager AM, et al. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues [J]. Nat Immunol, 2003, 4: 965-973. (Pubitemid 37265917)
8. Ott VL, Cambier JC, Kappler J, et al. Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4 [J]. Nat Immunol, 2003, 4: 974-981. (Pubitemid 37265918)
9. Tager AM, Bromley SK, Medoff BD, et al. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment [J]. Nat Immunol, 2003, 4: 982-990.
10. Ford-Hutchinson AW. Leukotriene B4 in inflammation [J]. Crit Rev Immunol, 1990, 10: 1-12.
11. Barnes PJ. Future advances in COPD therapy [J]. Respiration, 2001, 68: 441-448.
12. Griffiths RJ, Pettipher ER, Koch K, et al. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis [J]. Proc Natl Acad Sci, 1995, 92: 517-521.
13. Tsuji F, Oki K, Fujisawa K, et al. Involvement of leukotriene B4 in arthritis models [J]. Life Sci, 1998, 64: PL51-56.
14. Ikai KJ. Psoriasis and the arachidonic acid cascade [J]. J Dermatol Sci, 1999, 21: 135-146.
15. Zhu YI, Stiller MJ. Preview of potential therapeutic applications of leukotriene B4 inhibitors in dermatology [J]. Skin Pharmacol Appl Skin Physiol, 2000, 13: 235-245.
16. Rola-Pleszczynski M, Lemaire I. Leukotrienes augment interleukin 1 production by human monocytes [J]. J Immunol, 1985, 135: 3958-3961. (Pubitemid 16250375)
17. Rola-Pleszczynski M, Chavaillaz PA, Lemaire I. Stimulation of interleukin 2 and interferon gamma production by leukotriene B4 in human lymphocyte cultures [J]. Prostaglandins Leukot Med, 1986, 23: 207-210. (Pubitemid 16041214)
18. Levine JD, Lau W, Kwiat G, et al. Leukotriene B4 produces hyperalgesia that is dependent on polymorpho-nuclear leukocytes [J]. Science, 1984, 225: 743-745.
19. Devchand PR, Keller H, Peters JM, et al. The PPARalpha-leukotriene B4 pathway to inflammation control [J]. Nature, 1996, 384: 39-43.
20. Ford-Hutchinson AW, Gresser M, Young RN. 5-Lipoxygenase [J]. Annu Rev Biochem, 1994, 63: 383-417.
21. Aharony D. Pharmacology of leukotriene receptor antagonists [J]. Am J Respir Crit Care Med, 1998, 157: S214-218.
22. Serbian CN. Lipoxin and novel aspirin triggered 15-epi-lipoxin (ATL): a jungle of cell-cell interact [J]. Prostaglandins, 1997, 53: 107-137.
23. Haeggstroem JZ. Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis [J]. J Biol Chem, 2004, 279: 50639-50642.
24. Rudberg PC, Tholander F, Thunnissen MM, et al. Leukotriene A4 hydrolase/aminopeptidase glutamate 271 is a catalytic residue with specific roles in two instinct mechanisms [J]. J Biol Chem, 2002, 277: 1398-1404. (Pubitemid 34975657)
25. Penning TD, Russel MA, Chen BB, et al. Synthesis of potent leukotriene A(4) hydrolase inhibitors identification of 3-(methyl (3-(4-(phenylmethyl) phenoxy) propyl) amino) propanoic acid [J]. J Med Chem, 2002, 45: 3482-3490.
26. MDL ISIS Draw 2.5. MDL Information systems, Inc, 2002.
27. Maestro-v8.0 Molecular Modeling Interface, Schrödinger LLC, New York, 2007.
28. HalgrenTA. MMFF VI. MMFF94s option for energy minimization studies [J]. J Comput Chem, 1999, 20: 720-729.
29. Kuntz ID. Structure-based strategies for drug design and discovery [J]. Science, 1992, 257: 1078-1082.
30. RCSB Protein Data Bank. http://www.rcsb.org/pdb, (PDB entry 3CHR).
31. So S, Karplus M. Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks [J]. J Med Chem, 1996, 39: 1521-1530. (Pubitemid 26108787)
32. Rogers D, Hopfinger AJ. Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships [J]. J Chem Inf Comput Sci, 1994, 34: 854-866.
33. Ginn CMR, Turner DB, Willett P, et al. Similarity searching in files of three-dimensional chemical structures: evaluation of the EVA descriptor and combination of rankings using data fusion [J]. J Chem Inf Comput Sci, 1997, 37: 23-37 (Pubitemid 127601576)
34. Breiman L. Random Forest [J]. Machine Learning, 2001, 45: 5-32.
35. Gangjee A, Vidwans AP, Vasudevan A, et al. Synthesis and dihydrofolate reductase inhibitor activities of 2, 4-diamino-5-deaza- and 2,4-diamino-5, 10-dideaza lipophilic antifolates [J]. J Med Chem, 1998, 41: 3426-3434.
36. Wang R, Lu Y, Wang S. Comparative evaluation of 11 scoring functions for molecular docking [J]. J Med Chem, 2003, 46: 2287-2303. (Pubitemid 36637914)
37. Oda A, Tsuchida K, Takakura T, et al. Comparison of strategies for evaluating computational models of protein-ligand complexes [J]. J Chem Inf Model, 2006, 46: 380-391. (Pubitemid 43282129)